Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution.".
Aurobindo Pharma Limited has informed the Exchange regarding a press release dated February 07, 2023, titled "Aurobindo Pharma receives USFDA Approval for Diclofenac Sodium Topical Solution.".